NCT06039644 2026-03-06
To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer
GenMont Biotech Incorporation
Phase NA Recruiting
Clinical Trials
6 trialsNCT06892093 2025-09-08
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT07044310 2025-07-29
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Mayo Clinic
Phase 2 Recruiting
NCT05562518 2025-07-23
GRACE
University Hospital, Ghent
Phase 4 Recruiting
NCT03358511 2020-05-21
Engineering Gut Microbiome to Target Breast Cancer
Mayo Clinic
Phase NA Completed
NCT01723592 2017-06-06
Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.
Medical University of Vienna
Phase NA Completed